MedStar Washington Hospital Center

Futó vizsgálatok

• Még nem toboroz

  NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices

  NCT07806149· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• Toboroz

  A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

  NCT07748208· 2. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

  NCT06458907· P+F Products + Features USA Inc.· Forrás

• Toboroz

  A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

  NCT07776691· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· 3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  NCT07324031· AtaCor Medical, Inc.· Forrás

• Toboroz

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

  NCT07258290· Teleflex· Forrás

• Még nem toboroz

  Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard

  NCT07375810· Heart Input Output Inc· Forrás

• Még nem toboroz

  Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support

  NCT07445932· Medstar Health Research Institute· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07210723· 2/3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  NCT07198074· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

  NCT07078383· Vascutek Ltd.· Forrás

• Toboroz

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  NCT06931340· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· 3. fázis· argenx· Forrás

• Toboroz

  Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  NCT06958328· 3. fázis· NRG Oncology· Forrás

• Fut, nem toboroz

  Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

  NCT06732401· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

  NCT06980103· Georgetown University· Forrás

• Toboroz

  A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

  NCT06774131· 3. fázis· UroGen Pharma Ltd.· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· 3. fázis· Pfizer· Forrás

• Toboroz

  PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

  NCT06422871· Merit Medical Systems, Inc.· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· 2. fázis· CSL Behring· Forrás

• Toboroz

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  NCT06846281· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

  NCT06658730· W.L.Gore & Associates· Forrás

• Toboroz

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  NCT06340568· 3. fázis· BioNTech SE· Forrás

• Toboroz

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)

  NCT06924970· 2. fázis· Agios Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  ASCEND CSP IDE Study

  NCT06830746· Abbott Medical Devices· Forrás

• Fut, nem toboroz

  TECTONIC CAD IVL IDE Study

  NCT06885177· Abbott Medical Devices· Forrás

• Toboroz

  Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  NCT06661720· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Fut, nem toboroz

  Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

  NCT06869785· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

  NCT06798558· 2. fázis· Hackensack Meridian Health· Forrás

• Toboroz

  Prevail Global Study

  NCT06535854· Medtronic Vascular· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· 2/3. fázis· BioNTech SE· Forrás

• Fut, nem toboroz

  Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

  NCT06760637· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

  NCT06632327· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás

• Meghívásos bevonás

  Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial

  NCT06243068· George Washington University· Forrás

• Toboroz

  QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

  NCT06551116· Abramson Cancer Center at Penn Medicine· Forrás

• Toboroz

  VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

  NCT06264180· 3. fázis· Replimune, Inc.· Forrás

• Toboroz

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

  NCT05907629· Yale University· Forrás

• Toboroz

  Technical Development of Cardiovascular Magnetic Resonance Imaging

  NCT04927429· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• Toboroz

  Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

  NCT05987241· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

  NCT05818150· Merit Medical Systems, Inc.· Forrás

• Fut, nem toboroz

  Stroke Research Initiative to Advance Equity

  NCT06075719· Medstar Health Research Institute· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Pfizer· Forrás

• Toboroz

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Orchestra BioMed, Inc· Forrás

Showing 50 of 153.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Aortic aneurysm8 toboroz
• Áttétes emlőrák6 toboroz
• Hólyagrák6 toboroz
• Koszorúér-betegség4 toboroz
• Prosztatarák4 toboroz
• Stroke (szélütés)4 toboroz
• Szívelégtelenség4 toboroz
• Tüdőrák4 toboroz
• Hipertrófiás kardiomiopátia3 toboroz
• Méhtestrák3 toboroz
• Melanóma3 toboroz
• Petefészekrák3 toboroz
• Vesedaganat3 toboroz
• Dilated cardiomyopathy2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hasnyálmirigyrák2 toboroz
• Krónikus vesebetegség2 toboroz
• Mielóma multiplex2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Tripla negatív emlőrák2 toboroz
• Vastagbélrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Amiloidózis1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Pajzsmirigyrák1 toboroz
• Peripheral artery disease1 toboroz
• Pitvarfibrilláció1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Ventricular tachycardia1 toboroz

Lezárt vizsgálatok

• Lezárult

  Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)

  NCT07763769· Medhub Ltd.· Forrás

• Lezárult

  A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

  NCT06637072· 4. fázis· argenx· Forrás

• Leállították

  Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

  NCT06364215· Jorge Romero· Forrás

• Lezárult

  Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

  NCT05966662· Shockwave Medical, Inc.· Forrás

• Lezárult

  HEAL-LAA Clinical Trial

  NCT05809596· Boston Scientific Corporation· Forrás

• Leállították

  Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.

  NCT05540353· Medstar Health Research Institute· Forrás

• Lezárult

  Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

  NCT05605964· 3. fázis· Sumitomo Pharma America, Inc.· Forrás

• Lezárult

  Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis Services for Cisgender Women

  NCT07318532· Medstar Health Research Institute· Forrás

• Lezárult

  PositiveLinks: mHealth for DC Cohort

  NCT04998019· George Washington University· Forrás

• Lezárult

  A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

  NCT05583526· 3. fázis· Pfizer· Forrás

• Toboroz

  Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

  NCT04865887· 2. fázis· Georgetown University· Forrás

• Lezárult

  Device Feasibility and Acceptability to Improve Insomnia in Cancer

  NCT05875129· Medstar Health Research Institute· Forrás

• Lezárult

  Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

  NCT05174312· Reprieve Cardiovascular, Inc· Forrás

• Lezárult

  Social Risk Factors and Discrimination in Cancer Survivorship

  NCT05301114· Medstar Health Research Institute· Forrás

• Lezárult

  STOP AF First Post-Approval Study

  NCT05227053· Medtronic Cardiac Ablation Solutions· Forrás

• Lezárult

  Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

  NCT05293639· Biosense Webster, Inc.· Forrás

• Lezárult

  mHealth for Breast Cancer Survivors With Insomnia

  NCT05233800· Medstar Health Research Institute· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

• Lezárult

  Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

  NCT05120193· Medtronic Cardiac Ablation Solutions· Forrás

• Visszavonták

  CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF

  NCT04239534· AtriCure, Inc.· Forrás

• Leállították

  Immunization With BCG Vaccine to Prevent Tuberculosis Infection

  NCT04453293· 3. fázis· Henry M. Jackson Foundation for the Advancement of Military Medicine· Forrás

• Lezárult

  Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System

  NCT05007925· Shockwave Medical, Inc.· Forrás

• Leállították

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

  NCT04949256· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Implementation and Effectiveness Trial of HN-STAR

  NCT04208490· Wake Forest University Health Sciences· Forrás

• Lezárult

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Toboroz

  Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  NCT03907046· 3. fázis· Yale University· Forrás

• Lezárult

  Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

  NCT04175626· Biotronik, Inc.· Forrás

• Lezárult

  SVC Occlusion in Subjects With Acute Decompensated Heart Failure

  NCT03836079· Abiomed Inc.· Forrás

• Lezárult

  Long-Term PF-06651600 for the Treatment of Alopecia Areata

  NCT04006457· 3. fázis· Pfizer· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Stemline Therapeutics, Inc.· Forrás

• Lezárult

  NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study

  NCT03929913· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• Lezárult

  Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke

  NCT03366129· National Institute of Neurological Disorders and Stroke (NINDS)· Forrás

• Lezárult

  OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

  NCT03487666· 2. fázis· Georgetown University· Forrás

• Lezárult

  Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

  NCT03048825· 3. fázis· Population Health Research Institute· Forrás

• Lezárult

  Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

  NCT03241459· SurModics, Inc.· Forrás

• Lezárult

  Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

  NCT02844816· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

  NCT03009981· 3. fázis· Alliance Foundation Trials, LLC.· Forrás

• Lezárult

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Mayo Clinic· Forrás

• Lezárult

  Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

  NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

  NCT01167712· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

  NCT00066690· 3. fázis· ETOP IBCSG Partners Foundation· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Sarcoidosis7 munka · 0 vizsgálat
• Follikuláris limfóma5 munka · 1 vizsgálat